← All stocks

Xenon Pharmaceuticals Inc.

XENE Scheduled selling only

CIK 0001582313 #1255 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$425.83K

$425.83K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$425.83K

$0.00 against sales at will

By person

11 insiders · 3 transactions

1.5×

Ian Mortimer holds only 1.5 times base salary in stock. $1.21M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

—

$425.83K (2) scheduled

−$425.83K

<0.0001%

$121.95

+100.0%

Svoronos Dawn

Director

—

31,373

0.0324%

$1.91M

+25.5%

PATOU GARY

Director

—

24,896

0.0257%

$1.52M

+5.6%

MORTIMER IAN

PRESIDENT & CEO

—

19,923

0.0206%

$1.21M

−36.4%

DiFabio Andrea

Chief Legal Officer

—

7,301

0.0075%

$445.19K

—

Machado Patrick

Director

—

2,645

0.0027%

$161.28K

—

Gover Justin D.

Director

—

2,645

0.0027%

$161.28K

—

GAROFALO ELIZABETH A.

Director

—

2,645

0.0027%

$161.28K

—

GANNON STEVEN

Director

—

1,870

0.0019%

$114.03K

−6.5%

Cannon Gillian

Director

—

1,455

0.0015%

$88.72K

—

AULIN SHERRY

Chief Financial Officer

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Svoronos Dawn

1 Sep 2026

Director

Exercised, kept

5,144

$8.15

$41.92K

KENNEY CHRISTOPHER JOHN

28 Aug 2026

Chief Medical Officer

Sold on a plan

700

$60.98

$42.68K

KENNEY CHRISTOPHER JOHN

28 Aug 2026

Chief Medical Officer

Sold on a plan

6,368

$60.17

$383.15K

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 2

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 5,144

History held since 27 Sep 2016